<DOC>
	<DOC>NCT00545259</DOC>
	<brief_summary>The study will evaluate the pharmacokinetic profile of AEB071 in the immediate post-transplant period in patients who have undergone their first liver transplant.</brief_summary>
	<brief_title>Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation</brief_title>
	<detailed_description />
	<criteria>Primary liver transplant recipients. Transplanted liver functioning at an acceptable level by 24 h posttransplant Patients started on tacrolimus therapy within 12 h posttransplant Previous transplantation or multiple organs transplantation Acute rejection Nonheart beating donor Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Organ transplant, liver, pharmacokinetics, AEB071, immunosuppression</keyword>
</DOC>